ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs MXN
16.6086
0.00%
Brent Oil
83.76
0.00%
Bitcoin
66,970.24
-0.16%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Aerie Pharmaceuticals Inc (AERI)

  7. Aerie Pharmaceuticals Inc (AERI) Noticias

AERI

Aerie Pharmaceuticals (AERI)

Aerie Pharmaceuticals Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:AERI
FechaHoraFuenteTítuloSímboloCompañía
01/12/202214:08Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:AERIAerie Pharmaceuticals Inc
22/11/202200:01Business WireAlcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening Company’s Ophthalmic Pharmaceutical BusinessNASDAQ:AERIAerie Pharmaceuticals Inc
21/11/202215:58Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AERIAerie Pharmaceuticals Inc
21/11/202210:47Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:AERIAerie Pharmaceuticals Inc
21/11/202209:03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AERIAerie Pharmaceuticals Inc
10/11/202215:09Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AERIAerie Pharmaceuticals Inc
04/11/202210:15TipRanksNeedham Remains a Hold on Aerie Pharma (AERI)NASDAQ:AERIAerie Pharmaceuticals Inc
04/11/202205:02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AERIAerie Pharmaceuticals Inc
07/10/202208:07Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (definitive) (defm14a)NASDAQ:AERIAerie Pharmaceuticals Inc
04/10/202221:18TipRanksUBX vs. AERI: Which Eyecare Stock Has the Most Upside Potential?NASDAQ:AERIAerie Pharmaceuticals Inc
04/10/202216:17ValueWalkSmall-Cap Catalyst Pharmaceuticals Is Among Market’s Best Price PerformersNASDAQ:AERIAerie Pharmaceuticals Inc
23/08/202216:16Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:AERIAerie Pharmaceuticals Inc
23/08/202209:11TipRanksWhat Does Aerie Buyout Mean for Alcon (NYSE:ALC)?NASDAQ:AERIAerie Pharmaceuticals Inc
23/08/202205:42Dow Jones NewsAerie Pharmaceuticals Shares Rise 34% After Alcon Buyout OfferNASDAQ:AERIAerie Pharmaceuticals Inc
22/08/202220:18Business WireAlcon to Acquire Aerie Pharmaceuticals, Inc., Enhancing its Ophthalmic Pharmaceutical PortfolioNASDAQ:AERIAerie Pharmaceuticals Inc
05/08/202205:41TipRanksNeedham Sticks to Their Buy Rating for Aerie Pharma (AERI)NASDAQ:AERIAerie Pharmaceuticals Inc
09/05/202205:29TipRanksAerie Pharma (AERI) Gets a Buy Rating from H.C. WainwrightNASDAQ:AERIAerie Pharmaceuticals Inc
06/05/202204:16TipRanksNeedham Thinks Aerie Pharma’s Stock is Going to RecoverNASDAQ:AERIAerie Pharmaceuticals Inc
26/04/202215:22Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:AERIAerie Pharmaceuticals Inc
13/04/202214:05TipRanksNeedham Maintains a Buy Rating on Aerie Pharma (AERI)NASDAQ:AERIAerie Pharmaceuticals Inc
25/02/202206:11Edgar (US Regulatory)Annual Report (10-k)NASDAQ:AERIAerie Pharmaceuticals Inc
09/02/202212:29Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:AERIAerie Pharmaceuticals Inc
03/01/202203:06TipRanksWall Street Analysts Are Bullish on Top Healthcare PicksNASDAQ:AERIAerie Pharmaceuticals Inc
31/12/202110:45TipRanksNeedham Keeps Their Buy Rating on Aerie Pharma (AERI)NASDAQ:AERIAerie Pharmaceuticals Inc
16/12/202110:50TipRanksNeedham Sticks to Its Buy Rating for Aerie Pharma (AERI)NASDAQ:AERIAerie Pharmaceuticals Inc
03/12/202112:15TipRanksAerie Pharma (AERI) Gets a Buy Rating from NeedhamNASDAQ:AERIAerie Pharmaceuticals Inc
08/11/202115:20Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:AERIAerie Pharmaceuticals Inc
21/10/202115:01Business WireAerie Pharmaceuticals Announces Presentation at the Ophthalmology Innovation Summit Glaucoma Innovation ShowcaseNASDAQ:AERIAerie Pharmaceuticals Inc
20/10/202108:11Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:AERIAerie Pharmaceuticals Inc
12/10/202105:30Business WireAerie Pharmaceuticals Announces Positive Phase 3 Topline Results for Netarsudil Ophthalmic Solution 0.02% Clinical Trial in JapanNASDAQ:AERIAerie Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:AERI

Su Consulta Reciente

BIT
P1QL82
BNP Paribas Issuance
COIN
NEETBTC
USOTC
GSPI
Green Star Products (PK)
BIT
UC3C6B
Unicredit Bank
BIT
P1SWP5
BNP Paribas Issuance
LSE
PU45
Euro.bk 37
EU
A699T
A699T
BIT
UI305C
Unicredit Bank
NASDAQ
WESTW
Westrock Coffee
LSE
BOOT
Boot (henry)
LSE
77BV
Investec Bnk 25
USOTC
PMREF
Primaris Real Estate Inv... (PK)
NASDAQ
FSWWX
Fidelity Sustainable Tar...
KUCN
CSIXUSDT
Carbon
LSE
83ZW
Int.fin. 23
BIT
S32132
Societe Generale Effekten
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados